Shilpa Medicare

Shilpa Medicare Limited is a prominent Indian pharmaceutical company specialising in the development, manufacture, and marketing of high-quality active pharmaceutical ingredients (APIs), formulations, biologics, and specialty chemicals.

Established in 1987 and headquartered in Raichur, Karnataka, Shilpa Medicare has evolved into a global brand, supplying affordable APIs and formulations to various regulated markets worldwide. The company operates multiple production facilities across India, each adhering to stringent international standards and specifications. Shilpa Medicare's commitment to innovation and quality has positioned it among the world's leading suppliers of oncology and non-oncology APIs, intermediates, and formulations.

Key Products and Services

Active Pharmaceutical Ingredients (APIs): Shilpa Medicare produces a diverse range of oncology and non-oncology APIs, including but not limited to anastrozole, capecitabine, gemcitabine HCl, and lenalidomide.

Formulations: The company offers various dosage forms such as tablets, capsules, liquid injections, lyophilized injectables, orally disintegrating films, and transdermal patches.

Biologics: Shilpa Medicare is advancing its portfolio in biologics and biosimilars, including monoclonal antibodies, microbial biosimilars, vaccines, and recombinant human albumin.

Contract Development and Manufacturing Organisation (CDMO) Services: The company provides comprehensive CDMO services, encompassing chemical development and manufacturing, high-potent API production, peptide synthesis, polymer development, continuous flow chemistry, and formulation development and manufacturing.

Shilpa Medicare Limited's unwavering dedication to quality, innovation, and affordability has solidified its reputation as a trusted partner in the global pharmaceutical industry. Through its extensive product offerings and services, the company continues to contribute significantly to global healthcare by ensuring access to essential and affordable medicines.